by TractManager | Dec 6, 2021 | Clinical Utility Evaluation
This report evaluates the clinical utility of pharmacogenomic testing to inform the selection or dose of medications for individuals diagnosed with depression, bipolar disorder, schizophrenia spectrum or other psychotic disorder, or anxiety disorder to improve...
by TractManager | Dec 6, 2021 | Health Technology Assessment
Focus of Report: This report focuses on the use of the NightBalance sleep position trainer (SPT) system for treatment of positional obstructive sleep apnea (POSA).Technology Description: The NightBalance consists of a palm-sized device that is worn across the chest...
by TractManager | Dec 1, 2021 | Health Technology Assessment
Focus of the Report: The focus of this report is on allogeneic hematopoietic stem cell transplantation (HSCT) utilizing alternative human leukocyte antigen (HLA)-matched donor sources in pediatric patients with sickle cell disease (SCD) without an HLA-matched sibling...
by TractManager | Nov 29, 2021 | Health Technology Assessment
Focus of the Report: This health technology assessment focuses on the efficacy and safety of the life under kinetic evolution (LUKE) arm (Mobius Bionics) for adults with upper extremity (or limb) amputation.Technology Description: Developed by DEKA Research and...
by TractManager | Nov 22, 2021 | Emerging Technology Report
Vosoritide is a longer-acting C-type natriuretic peptide (CNP) analog that modulates activity of the fibroblast growth factor receptor 3 (FGFR3) by inhibiting a signaling pathway that mediates its effects, thereby stimulating endochondrial growth, resulting in...
Recent Comments